CPDR is a program of the Uniformed Services University of the Health Sciences
and the Henry M. Jackson Foundation for the Advancement of Military Medicine

< Publications Archive

> 2001 Publications

11-20

 

1. The D’Amico Article Reviewed: The CPDR/CaPSURE Recurrence Equation.
Moul JW.
Oncology, 15:1060-1062, 2001.

 

2. Use of Serum Creatinine to Predict Pathologic Stage and Recurrence Among Radical Prostatectomy Patients.
Merseburger AS, Connelly RR, Sun L, Richter E, Moul JW:
Urology, 58:729-734, 2001.

 

3. The Development of Erectile Dysfunction in Men Treated for Prostate Cancer.
Siegel T, Moul JW, Spevak M, Alvord WG, and Costabile RA:
Journal of Urology, Vol. 165,430-435, 2001.

 

4. PSA Enhanced Testing and Risk Stratification for Chemoprevention Trials.
Moul JW:
Urology, 57 (Suppl 4A): 174-177, 2001.

 

5. A comparison of radical retropubic with perineal prostatectomy for localized prostate cancer within the Uniformed Services Urology Research Group.
Lance RS, Freidrichs PA, Kane C, Powell CR, Pulos E, Moul JW, McLeod DG, Cornum RL, and Thrasher JB:
BJU International. Vol. 87:61-65, 2001.

 

6. Quantitative Expression Profile of Androgen-Regulated Genes in Prostate Cancer Cells and Identification of Prostate-Specific Genes.
Xu LL, Su YP, LaBiche R, Segawa T, Shanmugam N, McLeod, Moul JW and Srivastava S:
Int. J. Cancer, Vol. 92:322-328, 2001.

 

7. Clinical Staging of Prostate Cancer: Reproducibility and Clarification of Issues.
Campbell T, Blasko J, Crawford ED, Forman J, Hanks G, Kuban D, Montie J, Moul JW, Pollack A, Raghavan D, Ray P, Roach III M, Steinberg G, Stone N, Thompson I, Vogelzang N, and Vijayakumar S:
Int. J. Cancer. (Radiat. Oncol. Invest), 96:198-209, 2001.

 

8. Age-Specific Reference Ranges for Prostate Specific Antigen in Young Men: Retrospective Study from the National Defense University.
Hartzell JD, Kao TC, Holland JC, Holt SR, and Moul JW:
The Prostate Journal, 3:36-41, 2001.

 

9. The Effect of Ethnicity on Biochemical Disease-Free Outcome in Patients with Prostate Cancer Treated with Definitive Radiation Therapy in an Equal-Access Health Care System: A Radiation Oncology Report of the Department of Defense Center for Prostate Disease Research.
Johnstone P, Kane C, Sun L, Wu H, Moul JW, et al:
Radiology, 2001.

 

10. Predicting risk of prostate specific antigen recurrence after radical prostatectomy with the Center for Prostate Disease Research and Cancer of the Prostate Strategic Urologic Research Endeavor databases.
Moul JW, Connelly RR, Lubeck DP, Bauer JJ, Sun L, Flanders SC, Grossfeld GD, Carroll PR:
J Urol, 166:1322-1327, 2001.